Michael Scolaro

Michael Scolaro

Aug 29, 2017

Group 6 Copy 204
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Decreasing the Risk of Death and Diving Injuries in Artisanal Fishermen

    Artisanal fishermen risk their lives every day to support their families and communities. Using outdated...

    Can we prevent the transmission of BRCA mutations?

    Women with the BRCA gene mutation have an 80% risk of developing breast or ovarian cancer. Most research...

    How can we create culturally competent workplaces for Muslim healthcare providers?

    Muslim healthcare providers constitute a growing, diverse and underrepresented population in the U.S. Culturally...

    Backer Badge Funded